The two major drugmakers Pfizer and Moderna, which are expected to receive U.S. emergency approval for a Corona vaccine in the coming weeks, have declined President Donald Trump’s invitation to the White House “vaccine summit.” About it writes the specialized portal “Stat”.
In November, Trump accused Pfizer of deliberately postponing the announcement of the success of the vaccine, developed jointly with the German company BioNTech, in order not to increase the chances of winning the current U.S. president. Nevertheless, Pfizer CEO Albert Bourla received an invitation to the White House event, writes “Stat”.
“The head of Moderna, Stéphane Bancel, has also been invited. But neither he nor the head of the other company will be present,” the statement added. The two manufacturers declined the invitation.
Earlier, “Stat” reported that the summit on the Corona vaccine is scheduled for December 8, which will be attended by Trump and U.S. Vice President Mike Pence, among others. It is noted that a number of pharmaceutical industry representatives and an unnamed Trump administration official view the upcoming event “largely” as a PR stunt.
Next Thursday, the U.S. Food and Drug Administration (FDA) will consider whether to grant emergency licensing for the serum developed by Pfizer and BioNTech. On Dec. 17, approval of Moderna’s vaccine is to be discussed. (om/ae)
by Jeremy Abbott – American Correspondent